Bridgebio Oncology Therapeutics, Inc. EFFECT Filing
Ticker: BBOT · Form: EFFECT · Filed: May 5, 2026 · CIK: 0001869105
| Field | Detail |
|---|---|
| Company | Bridgebio Oncology Therapeutics, Inc. (BBOT) |
| Form Type | EFFECT |
| Filed Date | May 5, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a EFFECT filing submitted by Bridgebio Oncology Therapeutics, Inc. (ticker: BBOT) to the SEC on May 5, 2026.
Where can I view the full EFFECT filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on May 5, 2026 regarding BridgeBio Oncology Therapeutics, Inc. (BBOT).